Halo Diagnostics
A Different Kind of Healthcare Company.
Your Health Is Personal
Healthcare services should be tailored to your specific needs. To get the care and treatment that is right for you, you and your doctor need to have a clear and detailed picture of your overall health. One-off tests and one-size-fits-all diagnostics cannot provide that. Personalized care requires an integrated approach. At HALO Dx, we’re developing next-generation AI technology to do just that. We use advanced imaging modalities, genomics, biomarker analysis, and more to provide a holistic picture of your wellbeing.
We believe that more knowledge means more power when it comes to making decisions about your care and treatment. We are doctors, nurses, engineers, scientists, and researchers on a mission to save lives with precision diagnostics.
Diagnostics designed for you.
Problem
One Size Does Not Fit All
Solution
Make It Personal
PRECISION DIAGNOSTIC ENSEMBLE
ADVANCED
IMAGING
MOLECULAR
DIAGNOSTICS
- Genomic & Biomarker Screening
- Prostate Specific Antigen (PSA) Testing
- Liquid Biopsies
- ExoDx Prostate Cancer Test
- Biocept Blood Biopsy
- Circulating Tumor Cell Tests
Improved insights
Prostate Cancer Screening
| 4.8% | Clinically significant prostate cancer missed by the best performing liquid biomarker test alone. |
| 0% | Clinically significant prostate cancer missed when the liquid biomarker test was combined with MRI. |
Committed to Progress
Laser Focal Therapy for Prostate Cancer
| 100% | Prostate cancer survival rate. |
| <1% | Erectile dysfunction compared to ~50% with whole gland prostatectomy. |
| <1% | Incontinence compared to over 25% risk with whole gland prostatectomy. |
| <1% | Infection compared to 4% with whole gland prostatectomy. |
In the News
Recent Articles
BRCA Genes and Women’s Cancer Risk
Why Multiomics is Healthcare’s Next Big Step
Are HPV and Breast Cancer Connected?
1. de la Calle CM, Fasulo V, Cowan JE, et al. Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer [published online ahead of print, 2020 Sep 8]. J Urol.
2. John Feller, Bernadette Greenwood, Wes Jones, Rob Toth, Steve Gunberg, and Jeffrey Herz. Outpatient Trans-Rectal MR-Guided Laser Focal Therapy Phase II Clinical Trial: Ten-Year Interim Results. PD17. 2020, April 1. J Urol.
